McKesson is a centralized distribution partner for the US government's COVID vaccine distribution effort.
The Janssen vaccine received Emergency Use Authorization from the US Food and Drug Administration on Feb. 27 and is the first one-shot COVID-19 vaccine to be authorized for use in the United States.
McKesson was selected by the US government in August 2020 to operate as the centralized distributor for frozen and refrigerated COVID-19 vaccines and ancillary supply kits needed to administer them.
In December 2020, McKesson began distributing the ancillary supply kits for Pfizer BioNTech's COVID-19 vaccine.
Later that month, the company began distributing Moderna's COVID-19 vaccine and ancillary supply kits.
McKesson has established four dedicated distribution centers which will be specifically used to distribute the Johnson and Johnson COVID-19 vaccine and future refrigerated vaccines.
The US government makes all program administration decisions, including where, when and how many vaccine doses McKesson will distribute.
McKesson is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions company.
Dicerna divests OXLUMO (lumasiran) royalty interest to Royalty Pharma
AbbVie submits SKYRIZI approval applications to US FDA and European Medicines Agency
Moderna's COVID-19 contractual vaccine orders for governments on track for April 2021
Gan & Lee Pharmaceuticals' GLR2007 receives European Medicines Agency orphan drug status
Bioniz Therapeutics' BNZ-1 receives European Commission orphan designation
WuXi Biologics completes US FDA Pre-License Inspection and routine GMP inspection